Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

iRhythm Technologies, Inc.

IRTCNASDAQ
Healthcare
Medical - Devices
$113.00
$-1.67(-1.46%)
U.S. Market opens in 15h 7m

iRhythm Technologies, Inc. Fundamental Analysis

iRhythm Technologies, Inc. (IRTC) shows moderate financial fundamentals with a PE ratio of -81.57, profit margin of -5.96%, and ROE of -38.33%. The company generates $0.7B in annual revenue with strong year-over-year growth of 20.13%.

Key Strengths

Cash Position16.01%
PEG Ratio-6.29
Current Ratio4.63

Areas of Concern

ROE-38.33%
Operating Margin-6.82%
We analyze IRTC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -11.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-11.2/100

We analyze IRTC's fundamental strength across five key dimensions:

Efficiency Score

Weak

IRTC struggles to generate sufficient returns from assets.

ROA > 10%
-4.37%

Valuation Score

Excellent

IRTC trades at attractive valuation levels.

PE < 25
-81.57
PEG Ratio < 2
-6.29

Growth Score

Excellent

IRTC delivers strong and consistent growth momentum.

Revenue Growth > 5%
20.13%
EPS Growth > 10%
10.15%

Financial Health Score

Moderate

IRTC shows balanced financial health with some risks.

Debt/Equity < 1
4.79
Current Ratio > 1
4.63

Profitability Score

Weak

IRTC struggles to sustain strong margins.

ROE > 15%
-3832.64%
Net Margin ≥ 15%
-5.96%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IRTC Expensive or Cheap?

P/E Ratio

IRTC trades at -81.57 times earnings. This suggests potential undervaluation.

-81.57

PEG Ratio

When adjusting for growth, IRTC's PEG of -6.29 indicates potential undervaluation.

-6.29

Price to Book

The market values iRhythm Technologies, Inc. at 23.79 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

23.79

EV/EBITDA

Enterprise value stands at -399.75 times EBITDA. This is generally considered low.

-399.75

How Well Does IRTC Make Money?

Net Profit Margin

For every $100 in sales, iRhythm Technologies, Inc. keeps $-5.96 as profit after all expenses.

-5.96%

Operating Margin

Core operations generate -6.82 in profit for every $100 in revenue, before interest and taxes.

-6.82%

ROE

Management delivers $-38.33 in profit for every $100 of shareholder equity.

-38.33%

ROA

iRhythm Technologies, Inc. generates $-4.37 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.37%

Following the Money - Real Cash Generation

Operating Cash Flow

iRhythm Technologies, Inc. produces operating cash flow of $81.01M, showing steady but balanced cash generation.

$81.01M

Free Cash Flow

iRhythm Technologies, Inc. produces free cash flow of $34.58M, offering steady but limited capital for shareholder returns and expansion.

$34.58M

FCF Per Share

Each share generates $1.07 in free cash annually.

$1.07

FCF Yield

IRTC converts 0.95% of its market value into free cash.

0.95%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-81.57

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-6.29

vs 25 benchmark

P/B Ratio

Price to book value ratio

23.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.87

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.79

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.38

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.06

vs 25 benchmark

How IRTC Stacks Against Its Sector Peers

MetricIRTC ValueSector AveragePerformance
P/E Ratio-81.5728.25 Better (Cheaper)
ROE-38.33%780.00% Weak
Net Margin-5.96%-20122.00% (disorted) Weak
Debt/Equity4.790.30 Weak (High Leverage)
Current Ratio4.634.66 Strong Liquidity
ROA-4.37%-14687.00% (disorted) Weak

IRTC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews iRhythm Technologies, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

123.41%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-68.15%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

112.56%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ